{\rtf1\ansi\deff0\deftab360

{\fonttbl
{\f0\fswiss\fcharset0 Arial}
{\f1\froman\fcharset0 Times New Roman}
{\f2\fswiss\fcharset0 Verdana}
{\f3\froman\fcharset2 Symbol}
}

{\colortbl;
\red0\green0\blue0;
}

{\info
{\author Biblio 7.x}{\operator }{\title Biblio RTF Export}}

\f1\fs24
\paperw11907\paperh16839
\pgncont\pgndec\pgnstarts1\pgnrestart
Webley WC, Norkin LC, Stuart ES.\'a0 2004.\'a0\'a0Caveolin-2 associates with intracellular chlamydial inclusions independently of caveolin-1.. BMC Infect Dis. 4:23.\par \par Webley WC, Vora GJ, Stuart ES.\'a0 2004.\'a0\'a0Cell surface display of the chlamydial glycolipid exoantigen (GLXA) demonstrated by antibody-dependent complement-mediated cytotoxicity.. Curr Microbiol. 49(1):13-21.\par \par Stuart ES, Webley WC, Norkin LC.\'a0 2003.\'a0\'a0Lipid rafts, caveolae, caveolin-1, and entry by Chlamydiae into host cells.. Exp Cell Res. 287(1):67-78.\par \par Mukherjee J, Chios K, Fishwild D, Hudson D, O'Donnell S, Rich SM, Donohue-Rolfe A, Tzipori S.\'a0 2002.\'a0\'a0Human Stx2-specific monoclonal antibodies prevent systemic complications of Escherichia coli O157:H7 infection.. Infect Immun. 70(2):612-9.\par \par Mukherjee J, Chios K, Fishwild D, Hudson D, O'Donnell S, Rich SM, Donohue-Rolfe A, Tzipori S.\'a0 2002.\'a0\'a0Production and characterization of protective human antibodies against Shiga toxin 1.. Infect Immun. 70(10):5896-9.\par \par Norkin LC, Wolfrom SA, Stuart ES.\'a0 2001.\'a0\'a0Association of caveolin with Chlamydia trachomatis inclusions at early and late stages of infection.. Exp Cell Res. 266(2):229-38.\par \par }